Journal of inflammation (London, England) · 2025
Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Santinon François, Papadopoulos Theodoros, Berg Meagan-Helen Henderson, McCallum Paige, Abraham Madelyn J, Gonçalves Christophe, Gupta Vrinda, Gagnon Natascha, Wirasinghe Noah, Chou Hsiang, Esfahani Khashayar, Bartish Margarita, Miller Wilson H, Del Rincon Sonia Victoria
Аннотация
BACKGROUND: Phosphorylation of eIF4E by MNK1/2 modulates protein synthesis by controlling the translation of specific mRNAs. Immune cells use the MNK1/2-eIF4E axis to adapt their gene expression in response to environmental cues, but its dysregulated activity promotes disease progression. While recent examples using cancer models have identified CD8+ T-cells as a conduit for the tumor-supporting role of the MNK1/2-eIF4E axis, the impact of phospho-eIF4E on CD4+ T-cell subsets, specifically regulatory T-cells, remains unclear. To fill this knowledge gap, we studied the impact of phospho-eIF4E-deficiency on Treg activity in mice in an inflammatory context using a model of murine colitis and in human PBMCs.
RESULTS: We found that Tregs isolated from mice deficient for phospho-eIF4E (expressing a serine-to-alanine mutation at S209) had a diminished ability to control CD4+ T-cell proliferation and IFNγ secretion in vitro. We further report aggravated colitis in mice deficient in phospho-eIF4E accompanied by an increase in CD4+ T-cells expressing IFNγ and a reduction in Tregs in the mesenteric lymph nodes and colon. Mechanistically, T-cells lacking phospho-eIF4E show impaired differentiation into Tregs, and Tregs lacking phospho-eIF4E have reduced FoxP3 expression and diminished migration to the lymph nodes. Using human PBMCs, anti-CTLA-4, but not anti-PD-1, reduced the phospho-eIF4E-expressing Treg population.
CONCLUSIONS: Taken together, these data highlight a role for phospho-eIF4E in Treg biology and in the control of inflammation.
CLINICAL TRIAL NUMBER: Not applicable.
RESULTS: We found that Tregs isolated from mice deficient for phospho-eIF4E (expressing a serine-to-alanine mutation at S209) had a diminished ability to control CD4+ T-cell proliferation and IFNγ secretion in vitro. We further report aggravated colitis in mice deficient in phospho-eIF4E accompanied by an increase in CD4+ T-cells expressing IFNγ and a reduction in Tregs in the mesenteric lymph nodes and colon. Mechanistically, T-cells lacking phospho-eIF4E show impaired differentiation into Tregs, and Tregs lacking phospho-eIF4E have reduced FoxP3 expression and diminished migration to the lymph nodes. Using human PBMCs, anti-CTLA-4, but not anti-PD-1, reduced the phospho-eIF4E-expressing Treg population.
CONCLUSIONS: Taken together, these data highlight a role for phospho-eIF4E in Treg biology and in the control of inflammation.
CLINICAL TRIAL NUMBER: Not applicable.